Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.18% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Franklin Covey
FC
$235M
| $4.63M | ﹤0.01% |
120,237
+42,886
| +55% | +$1.98M |
|
3877
PUT
BridgeBio Pharma
BBIO
$16.4B
| $4.62M | ﹤0.01% |
278,800
+264,300
| +1,823% | +$3.08M |
|
3878
NerdWallet
NRDS
$625M
| $4.62M | ﹤0.01% |
285,477
+266,984
| +1,444% | +$4.02M |
|
3879
PUT
iShares MSCI Spain ETF
EWP
$2.21B
| $4.62M | ﹤0.01% |
165,700
+118,100
| +248% | +$3.17M |
|
3880
Biohaven
BHVN
$2.19B
| $4.61M | ﹤0.01% |
337,527
+270,575
| +404% | +$4.31M |
|
3881
CALL
Kinross Gold
KGC
$32.3B
| $4.61M | ﹤0.01% |
978,800
+228,600
| +30% | +$969K |
|
3882
CALL
iShares Core S&P Total US Stock Market ETF
ITOT
$97.5B
| $4.61M | ﹤0.01% |
50,900
-69,600
| -58% | -$6.18M |
|
3883
iShares Dow Jones US ETF
IYY
$3.06B
| $4.61M | ﹤0.01% |
+46,026
| New | +$4.5M |
|
3884
Primoris Services
PRIM
$4.42B
| $4.6M | ﹤0.01% |
186,677
-276,199
| -60% | -$6.98M |
|
3885
Codexis
CDXS
$159M
| $4.6M | ﹤0.01% |
1,111,849
+152,149
| +16% | +$798K |
|
3886
CALL
Jones Lang LaSalle
JLL
$16.7B
| $4.6M | ﹤0.01% |
31,600
+5,600
| +22% | +$933K |
|
|
RVNC
3887
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.6M | ﹤0.01% |
142,700
+7,200
| +5% | +$224K |
|
3888
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$540M
| $4.59M | ﹤0.01% |
108,900
+17,500
| +19% | +$665K |
|
3889
Crinetics Pharmaceuticals
CRNX
$8.95B
| $4.59M | ﹤0.01% |
285,595
+248,239
| +665% | +$4.59M |
|
3890
Fabrinet
FN
$18.8B
| $4.59M | ﹤0.01% |
38,612
-16,355
| -30% | -$2.03M |
|
|
ADAM
3891
Adamas Trust
ADAM
$919M
| $4.58M | ﹤0.01% |
460,300
+141,644
| +44% | +$1.53M |
|
3892
CALL
Chemours
CC
$2.23B
| $4.58M | ﹤0.01% |
153,000
-85,700
| -36% | -$2.82M |
|
3893
JPMorgan BetaBuilders Japan ETF
BBJP
$18.8B
| $4.58M | ﹤0.01% |
94,622
-13,673
| -13% | -$642K |
|
3894
Samsara
IOT
$23.5B
| $4.56M | ﹤0.01% |
231,388
-262,887
| -53% | -$4.17M |
|
3895
TaskUs
TASK
$633M
| $4.56M | ﹤0.01% |
315,984
+279,332
| +762% | +$4.86M |
|
3896
Kanzhun
BZ
$7.49B
| $4.56M | ﹤0.01% |
239,471
+101,908
| +74% | +$2.22M |
|
3897
Vanguard FTSE Pacific ETF
VPL
$8.42B
| $4.55M | ﹤0.01% |
+67,134
| New | +$4.51M |
|
3898
PUT
Sprott Uranium Miners ETF
URNM
$2.03B
| $4.55M | ﹤0.01% |
145,100
-111,900
| -44% | -$3.74M |
|
|
INZY
3899
DELISTED
Inozyme Pharma
INZY
| $4.55M | ﹤0.01% |
+793,823
| New | +$2.1M |
|
3900
PUT
Calumet Specialty Products
CLMT
$4.05B
| $4.55M | ﹤0.01% |
261,600
+137,200
| +110% | +$2.44M |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,467 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.